COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
tata india pharma & healthcare fund direct payout of inc dist cum cap wdrl
Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl

Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl

  • Very High Risk
  • Equity
  • Sector - Healthcare
Share
  • Whatsapp
  • Twitter
  • Facebook
NAV as on Aug 6, 2025
i
Price per unit of the scheme.
35.0223-1.41%1 Day Change
-0.37%
Minimum Investment₹5000
Expense Ratio0.97%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions
 

bt_logoFUND PERFORMANCE

As On Aug 06, 2025
Compare fund’s performance against category average across different time periods
20Out of 24 funds in the category
Category Avg Return
-1.13%
Fund Return -0.37%
Low-1.13%11.79%High
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

bt_logoFUND COMPARISON



No Data Found.
*For the other fund, rescaled NAVs are used
Share
  • Whatsapp
  • Twitter
  • Facebook

bt_logoRETURN CALCULATOR

Check the return on your investment in the fund
Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl
Investment Type
Monthly Investment
Time Period (yrs)
Annual Return in %
  • Invested Amount
    0
  • Return
    0
  • Current Value
    0

bt_logoFUND MANAGER

Meeta Shetty
Meeta Shetty
i
Lead Fund Manager.
Mar 9, 2021 - Present
  • Fund Manager Rank7Out of 22
    i
    Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
  • Schemes managed6
  • Total AUM27,554.34 Cr
  • Highest Return In 1 Yr7.80 %
Other Funds
  • table
  • card
1M
3M
6M
1Y
3Y
5Y
Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
--
₹ 52.51
-6.43%
-7.09%
Very High Risk
12,216.31Cr
₹ 25.08
-1.92%
-2.43%
Very High Risk
1,847.49Cr
--
₹ 14.01
-4.48%
-7.09%
Very High Risk
126.13Cr
Tata Digital India Fund Direct Growth
Very High Risk--
  • NAV₹ 52.51
  • Fund Size12,216.31Cr
Fund Return-6.43%
Category Return-7.09%
Tata Focused Equity Fund Direct Growth
Very High Risk
  • NAV₹ 25.08
  • Fund Size1,847.49Cr
Fund Return-1.92%
Category Return-2.43%
Tata Nifty India Digital ETF Fund of Fund Direct Growth
Very High Risk--
  • NAV₹ 14.01
  • Fund Size126.13Cr
Fund Return-4.48%
Category Return-7.09%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
Rajat Srivastava
Rajat Srivastava
i
Lead Fund Manager.
Sep 16, 2024 - Present
  • Schemes managed1
  • Total AUM1,281.99 Cr
  • Highest Return In 1 Yr7.80 %
Other Funds
  • table
  • card
1M
3M
6M
1Y
3Y
5Y
Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size
--
₹ 35.02
-0.37%
-0.95%
Very High Risk
1,281.99Cr
Tata India Pharma & Healthcare Fund Direct Growth
Very High Risk--
  • NAV₹ 35.02
  • Fund Size1,281.99Cr
Fund Return-0.37%
Category Return-0.95%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

bt_logoDETAILED PORTFOLIO

As on Jun, 2025
EQUITY (92.32%)
DEBT (-%)
CASH (7.68%)
Allocation by Market Cap
Large Cap(27.56%)
Mid Cap(32.77%)
Small Cap(30.50%)
Industry Holdings
  • Drug Manufacturers Specialty Generic58.88%
  • Medical Care24.65%
  • Diagnostics Research5.27%
  • Drug Manufacturers Major2.66%
  • Health Care Plans1.88%
  • Medical Instruments Supplies1.61%
Stock Holdings
  • Sun Pharmaceuticals Industries Ltd11.17%
  • Apollo Hospitals Enterprise Ltd7.19%
  • Cipla Ltd5.76%
  • Divi's Laboratories Ltd5.58%
  • Aurobindo Pharma Ltd5.44%
  • Fortis Healthcare Ltd5.30%

bt_logoPERFORMANCE MEASURES

Fund evaluation across critical parameters for better decision making. Study period is 3 years.
  • Consistency
    i
    It represents the consistency of a fund in beating its benchmark.
    ----
  • Downside Risk
    i
    Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
    ----
  • Risk Adjusted Return
    i
    Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
    ----
  • Volatility
    i
    Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
    ----
  • Upside Capture Ratio
    i
    Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
    ----
  • Downside Capture Ratio
    i
    Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.
    ----

bt_logoHISTORICAL RISK MEASURES

Statistical measures to evaluate mutual fund risk. All ratios are calculated for a three-year time duration.
  • Alpha: Excess return of the fund over benchmark
    i
    Any Alpha above zero is considered good. However, for comparison, a fund with a higher Alpha is considered better. Alpha is normally used in conjunction with Beta. If the Beta is high, it implies that the fund manager took a high risk to generate Alpha.
    0.55
    This Fund
    VS
    -0.07
    Category Avg
  • R-Squared: How well the fund tracks benchmark
    i
    R-Squared measures the correlation of fund returns and its benchmark returns. It varies between 0 and 1. The metric, Beta makes no sense if R-Squared is equal to zero. Thus, both Beta and R-Squared should be used in conjunction. A fund with a high R-Squared and low Beta is considered a less risky fund.
    97.18
    This Fund
    VS
    94.29
    Category Avg
  • Beta: Risk of the fund in relation to benchmark
    i
    Beta >1 indicates that the fund is more volatile than its benchmark while Beta < 1 indicates that the fund is less volatile than its benchmark. The Beta of the benchmark is equal to 1.
    0.99
    This Fund
    VS
    0.96
    Category Avg
  • Sharpe Ratio: Risk adjusted return of the fund
    i
    Sharpe Ratio is a measure of return per unit of risk. A higher Sharpe ratio indicates better risk adjusted return given by the fund.
    1.14
    This Fund
    VS
    1.09
    Category Avg
  • Sortino Ratio: Return per unit of bad risk
    i
    A variation of Sharpe ratio, Sortino considers only the downside risk. Unlike Sharpe ratio which considers both good risk and bad risk, Sortino factors only the bad risk. A high Sortino ratio indicates better return for each unit of downside risk.
    2.08
    This Fund
    VS
    1.99
    Category Avg
  • Standard Devation: Volatility of the fund
    i
    Standard deviation is a measure of dispersion of fund returns from its average return. A fund with a higher Standard deviation is more volatile than a fund with a low standard deviation.
    15.80
    This Fund
    VS
    15.60
    Category Avg
Benchmark used in calculation : S&P BSE 500 India TR INR

bt_logoPEER ANALYSIS

1M
3M
6M
1Y
3Y
5Y
  • card
  • table
Fund NameMorningstar RatingNAV Fund Return Category ReturnRisk Fund Size
--
₹ 31.66
0.84%
-0.95%
Very High Risk
₹ 87.70 Cr
--
₹ 249.78
0.16%
-0.95%
Very High Risk
₹ 1,098.70 Cr
--
₹ 249.78
0.16%
-0.95%
Very High Risk
₹ 1,098.70 Cr
IDBI Healthcare Fund Direct Transfer of Income Distribution cum Cap Wdrl plan
Very High Risk--
  • NAV₹ 31.66
  • Fund Size₹ 87.70 Cr
Fund Return0.84%
Category Return-0.95%
IDBI Healthcare Fund Direct Payout of Income Distribution cum Cap Wdrl
Very High Risk--
  • NAV₹ 31.66
  • Fund Size₹ 87.70 Cr
Fund Return0.84%
Category Return-0.95%
IDBI Healthcare Fund Direct Reinvestment of Income Distribution cum Cap Wdrl
Very High Risk--
  • NAV₹ 31.66
  • Fund Size₹ 87.70 Cr
Fund Return0.84%
Category Return-0.95%
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl
Very High Risk--
  • NAV₹ 249.78
  • Fund Size₹ 1,098.70 Cr
Fund Return0.16%
Category Return-0.95%
UTI Healthcare Fund-Direct Payout Inc Dist cum Cap Wdrl
Very High Risk--
  • NAV₹ 249.78
  • Fund Size₹ 1,098.70 Cr
Fund Return0.16%
Category Return-0.95%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
Very High Risk--
  • NAV₹ 23.18
  • Fund Size₹ 840.48 Cr
Fund Return0.00%
Category Return-0.95%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

bt_logoTOP FUNDS FROM THIS AMC

1M
3M
6M
1Y
3Y
5Y
  • card
  • table
Fund NameMorningstar RatingNAV Fund Return Category Return Risk Fund Size (Cr)
--
₹ 51.11
2.16%
--
Very High Risk
₹ 2,457.37 Cr
₹ 13.49
0.70%
0.41%
Moderate Risk
₹ 213.01 Cr
--
₹ 433.47
0.63%
--
Moderate Risk
₹ 12.13 Cr
--
₹ 80.12
0.63%
--
Low to Moderate Risk
₹ 15.12 Cr
--
₹ 15.22
0.60%
0.50%
Low Risk
₹ 15,922.05 Cr
Tata India Consumer Fund Direct Growth
Very High Risk--
  • NAV₹ 51.11
  • Fund Size₹ 2,457.37 Cr
1 Month Return2.16%
Category Return--
Tata Banking & PSU Debt Fund Direct Growth
Moderate Risk
  • NAV₹ 13.49
  • Fund Size₹ 213.01 Cr
1 Month Return0.70%
Category Return0.41%
Tata Medium Term Fund Segregated Portfolio 1 Direct Plan Growth
Moderate Risk--
  • NAV₹ 2.40
  • Fund Size₹ 2.15 Cr
1 Month Return0.64%
Category Return--
Tata Corporate Bond Segregated Portfolio 1 Direct Plan Growth
Moderate Risk--
  • NAV₹ 433.47
  • Fund Size₹ 12.13 Cr
1 Month Return0.63%
Category Return--
Tata Treasury Advantage Fund Segregated Portfolio 1 Direct Plan Growth
Low to Moderate Risk--
  • NAV₹ 80.12
  • Fund Size₹ 15.12 Cr
1 Month Return0.63%
Category Return--
Tata Arbitrage Fund Direct Growth
Low Risk--
  • NAV₹ 15.22
  • Fund Size₹ 15,922.05 Cr
1 Month Return0.60%
Category Return0.50%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

bt_logoABOUT THE AMC

company icon
Tata Asset Management Limited
Tata Asset Management Limited manages assets worth ₹ 2,07,269.15 crores. It’s current offering of mutual fund schemes includes 36 equity, 18 debt and 9 hybrid schemes.
phone icon
Phone
+91 22 6657 8282
mail icon
Email
kiran@tataamc.com
aum
AUM
2,07,269.15 Cr (
As on Jun 30, 2025
)
location
Address
Mafatlal Centre, 9th Floor, Mumbai,400 021

bt_logoFAQ's

What is the category of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl ?
The category of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl is Equity - Sector - Healthcare
What is the current NAV of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl ?
The current NAV of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl as on Aug 06, 2025 is ₹35.02
How safe is Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl ?
The risk level of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl is Very High.
What are short term returns given by Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl ?
The return given by Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl in 1 month is -0.37%, 3 months is 4.16%, 6 months is 2.46%, and 1 year is 7.80%
What are the long term returns given by Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl ?
The return given by Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl in 3 years is 24.70% and 5 years is 21.13%.
What is the expense ratio of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl ?
The expense ratio of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl is 0.97%
What is the AUM of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl ?
The assets under Management (AUM) of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl is Rs 1,281.99 crores.
What is the minimum investment in Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl ?
The minimum Lumpsum investment in Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl is ₹5,000.00 and the minimum SIP investment in Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl is ₹1,000.00
What is the asset allocation of Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl?
Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl has an exposure of 92.32% in Equity and 7.68% in Cash & Money Market Securities